Seminars in Oncology
Volume 29, Issue 3 , Pages 213-221, June 2002

Issues and barriers to development of clinically useful tumor markers: A development pathway proposal☆

Program for the Assessment of Clinical Cancer Tests (PACCT), Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Address reprint requests to M. Elizabeth H. Hammond MD, MD, Department of Pathology, LDS Hospital, 8th Ave and C St, Salt Lake City, UT 84143.

PII: S0093-7754(02)50177-9

doi:10.1053/sonc.2002.32896

Seminars in Oncology
Volume 29, Issue 3 , Pages 213-221, June 2002

Article Tools